¶óÆæÆ®¦¢Ä«Æä¦¢ºí·Î±×¦¢´õº¸±â
¾ÆÄ«µ¥¹Ì Ȩ ¸í»çƯ°­ ´ëÇבּ¸½Ç޹æ Á¶°æ½Ç¹« µ¿¿µ»ó°­ÀÇ Çѱ¹ÀÇ ÀüÅëÁ¤¿ø ÇÐȸº° ³í¹®
ÇÐȸº° ³í¹®

Çѱ¹°Ç¼³°ü¸®ÇÐȸ
Çѱ¹°ÇÃà½Ã°øÇÐȸ
Çѱ¹µµ·ÎÇÐȸ
Çѱ¹»ý¹°È¯°æÁ¶ÀýÇÐȸ
Çѱ¹»ýÅÂÇÐȸ
Çѱ¹¼öÀÚ¿øÇÐȸ
Çѱ¹½Ä¹°ÇÐȸ
Çѱ¹½Ç³»µðÀÚÀÎÇÐȸ
Çѱ¹ÀÚ¿ø½Ä¹°ÇÐȸ
Çѱ¹ÀܵðÇÐȸ
Çѱ¹Á¶°æÇÐȸ
Çѱ¹Áö¹Ý°øÇÐȸ
Çѱ¹ÇÏõȣ¼öÇÐȸ
Çѱ¹È¯°æ»ý¹°ÇÐȸ
Çѱ¹È¯°æ»ýÅÂÇÐȸ

Çѱ¹¼öÀÚ¿øÇÐȸ / v.39, no.1, 2006³â, pp.11-22
´ÙÂ÷¿ø È«¼öÇÇÇØ»êÁ¤¹æ¹ý (¥±): Àû¿ë
( Multi-Dimensional Flood Damage Analysis (¥±): Application )
Ãֽ¾È;ÀÌÃæ¼º;½É¸íÇÊ;±èÇü¼ö; ÀÎÇÏ´ëÇб³ ȯ°æÅä¸ñ°øÇкÎ;ÀÎÇÏ´ëÇб³ ȯ°æÅä¸ñ°øÇкÎ;ÀÎÇÏ´ëÇб³ ȯ°æÅä¸ñ°øÇкÎ;ÀÎÇÏ´ëÇб³ ȯ°æÅä¸ñ°øÇкÎ;
 
ÃÊ ·Ï
º» ³í¹®¿¡¼­´Â ÇöÀç °Ç¼³ÁßÀÎ ±¼Æ÷õ ¹æ¼ö·Î »ç¾÷¿¡ ´ëÇÑ °æÁ¦¼ººÐ¼®À» À§ÇÏ¿© ±âÁ¸ °³¼±¹ý°ú ´ÙÂ÷¿ø¹ýÀ» Àû¿ëÇÏ¿© ºñ±³ ºÐ¼®ÇÏ¿´´Ù. ºñ±³ºÐ¼®°á°ú, µÎ ¹æ¹ý ¸ðµÎ °æÁ¦Àû Ÿ´ç¼ºÀ» ¸¸Á·ÇÏ¿´Áö¸¸ ´ÙÂ÷¿ø¹ýÀ¸·Î ºÐ¼®ÇÏ¿´À» ¶§ ´õ ¸¹Àº ÆíÀÍÀ» ³»´Â °ÍÀ¸·Î ³ªÅ¸³µ´Ù. ±×·¯³ª, °³¼±¹ýÀº »óȲ¿¡ µû¸¥ ¿¬Æò±ÕÆíÀÍ¿¡¼­ Å« Â÷À̸¦ ³ªÅ¸³»Áö ¾Ê¾ÒÀ¸³ª, ÀÌ¿¡ ºñÇØ¼­ ´ÙÂ÷¿ø¹ýÀº 20m Àӽùæ¼ö·Î °Ç¼³ ÈÄÀÇ ¿¬Æò±Õ ÆíÀÍÀÌ °³¼±¹ý°ú Å« Â÷À̸¦ º¸ÀÌÁö ¾Ê´Â ´ë½Å ¹æ¼ö·Î °Ç¼³ ÀüÀº °³¼±¹ýº¸´Ù ÈξÀ Å©°Ô »êÁ¤µÇ¾úÀ¸¸ç 80m ¹æ¼ö·Î °Ç¼³ ÈÄ¿¡´Â °³¼±¹ýº¸´Ù ÈξÀ ÀÛÀº ÇÇÇØ¾×ÀÌ »êÁ¤µÇ¾ú´Ù. Áï, ÇÇÇØÁö¿ªÀÇ Æ¯¼ºÀ» ¹Ý¿µÇϸç, »óȲ¿¡ µû¶ó ÀûÀýÇÏ°Ô ¿¹»óÇÇÇØ¾×À» »êÁ¤ÇÒ ¼ö ÀÖ¾ú´Ù. Ä¡¼ö»ç¾÷¿¡ À־ ¼ö°èÀüüÀÇ ÀÔÀåÀ» °í·ÁÇÑ È¿À»ÀûÀÎ ¹æ½ÄÀ» ½ÇÇöÇϰí ÇÕ¸®ÀûÀÎ ±âÁØ¿¡ µû¶ó Ä¡¼ö»ç¾÷ÀÌ ÃßÁøµÉ ¼ö ÀÖÀ¸¸®¶ó ÆÇ´ÜµÈ´Ù.
This study is that MD-FDA and the existing method were applied together the outlet project under the construction in the Gulpo River basin. The results of both of them mot the economic feasibility of the Project. But, MD-FDA evaluated the suitable damage according to situations; 1) without project, 2) after 20m outlet construction, 3) after 80m outlet construction. That is, MD-FDA could exactly evaluate the Annual Expected Flood Damage by considering the characteristics to the inundated area. If M-FDA may use in the flood control projects, the projects will be able to be taken into account all characteristics of the total damage area and performed by reasonable criteria.
 
Ű¿öµå
´ÙÂ÷¿ø¹ý;°³¼±¹ý;°æÁ¦¼ººÐ¼®;¿¬Æò±ÕÆíÀÍ;MD-FDA;economic analysis;annual average benefit;
 
Çѱ¹¼öÀÚ¿øÇÐȸ³í¹®Áý / v.39, no.1, 2006³â, pp.11-22
Çѱ¹¼öÀÚ¿øÇÐȸ
ISSN : 1226-6280
UCI : G100:I100-KOI(KISTI1.1003/JNL.JAKO200612842599880)
¾ð¾î : Çѱ¹¾î
³í¹® Á¦°ø : KISTI Çѱ¹°úÇбâ¼úÁ¤º¸¿¬±¸¿ø
¸ñ·Ïº¸±â
ȸ»ç¼Ò°³ ±¤°í¾È³» ÀÌ¿ë¾à°ü °³ÀÎÁ¤º¸Ãë±Þ¹æÄ§ Ã¥ÀÓÀÇ ÇѰè¿Í ¹ýÀû°íÁö À̸ÞÀÏÁÖ¼Ò ¹«´Ü¼öÁý °ÅºÎ °í°´¼¾ÅÍ
   

ÇÏÀ§¹è³ÊÀ̵¿